The incidence of bladder cancer is on the increase in Sweden. The purpose of the project is to apply molecular classification with RNA sequencing technology in clinical practice to bladder cancer cases. By analysing the expression of every gene in the tumour cells, bladder cancer can be classified into subtypes, which have different prognosis and respond differently to different treatments, such as chemotherapy. By applying real-time technology, where subtypes based on RNA expression are reported to the treating urologists, a better understanding of which treatment is best for the individual / patient is achievable.
Menu